Health Catalyst closed at $1.59 on Nov 4, up 10.42%, 49.4% below its 52-week closing high. Volume of 310.8K shares was 0.77× its 20-day average (below normal).
Split-adjusted performance: -10.2% over one month, +1.3% over six months, -49.4% over one year.
In the quarter ended Jun 30, 2026, revenue was $70.49M, down 12.7% from a year earlier, with a net margin of -57.5%.
Short interest was 2.1M shares at the Oct 15 settlement, down 6.6% from the prior report (3.5% of float, 4.4 days to cover).